Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for 908 Devices (MASS) over the last 6 years, with Q3 2025 value amounting to -$8000.0.

  • 908 Devices' Gains from Investment Securities rose 5789.47% to -$8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$694000.0, marking a year-over-year decrease of 43798.45%. This contributed to the annual value of -$559000.0 for FY2024, which is 51407.41% down from last year.
  • Per 908 Devices' latest filing, its Gains from Investment Securities stood at -$8000.0 for Q3 2025, which was up 5789.47% from -$3.5 million recorded in Q2 2025.
  • In the past 5 years, 908 Devices' Gains from Investment Securities ranged from a high of $3.3 million in Q1 2025 and a low of -$3.5 million during Q2 2025
  • Its 5-year average for Gains from Investment Securities is -$2315.8, with a median of -$8000.0 in 2025.
  • Examining YoY changes over the last 5 years, 908 Devices' Gains from Investment Securities showed a top increase of 797142.86% in 2025 and a maximum decrease of 4991428.57% in 2025.
  • Quarter analysis of 5 years shows 908 Devices' Gains from Investment Securities stood at -$521000.0 in 2021, then soared by 142.99% to $224000.0 in 2022, then crashed by 133.48% to -$75000.0 in 2023, then tumbled by 573.33% to -$505000.0 in 2024, then soared by 98.42% to -$8000.0 in 2025.
  • Its Gains from Investment Securities was -$8000.0 in Q3 2025, compared to -$3.5 million in Q2 2025 and $3.3 million in Q1 2025.